- Home
- BPT vs COSM Comparison
BPT vs COSM Comparison
Compare BPT & COSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BPT
- COSM
- Stock Information
- Founded
- BPT 1989
- COSM 2009
- Country
- BPT United States
- COSM United States
- Employees
- BPT N/A
- COSM N/A
- Industry
- BPT Integrated oil Companies
- COSM Other Pharmaceuticals
- Sector
- BPT Energy
- COSM Health Care
- Exchange
- BPT Nasdaq
- COSM Nasdaq
- Market Cap
- BPT 22.3M
- COSM 19.4M
- IPO Year
- BPT N/A
- COSM 2013
- Fundamental
- Price
- BPT $0.46
- COSM $0.86
- Analyst Decision
- BPT
- COSM
- Analyst Count
- BPT 0
- COSM 0
- Target Price
- BPT N/A
- COSM N/A
- AVG Volume (30 Days)
- BPT 441.1K
- COSM 320.4K
- Earning Date
- BPT 03-13-2025
- COSM 11-14-2024
- Dividend Yield
- BPT N/A
- COSM N/A
- EPS Growth
- BPT N/A
- COSM N/A
- EPS
- BPT N/A
- COSM N/A
- Revenue
- BPT $257,000.00
- COSM $56,042,109.00
- Revenue This Year
- BPT N/A
- COSM $4.53
- Revenue Next Year
- BPT N/A
- COSM $25.00
- P/E Ratio
- BPT N/A
- COSM N/A
- Revenue Growth
- BPT N/A
- COSM 13.01
- 52 Week Low
- BPT $0.40
- COSM $0.47
- 52 Week High
- BPT $3.20
- COSM $1.58
- Technical
- Relative Strength Index (RSI)
- BPT 32.36
- COSM 67.69
- Support Level
- BPT $0.40
- COSM $0.51
- Resistance Level
- BPT $0.57
- COSM $0.95
- Average True Range (ATR)
- BPT 0.07
- COSM 0.08
- MACD
- BPT -0.00
- COSM 0.02
- Stochastic Oscillator
- BPT 13.58
- COSM 78.95
About BPT BP Prudhoe Bay Royalty Trust
BP Prudhoe Bay Royalty Trust is a grantor trust operating in the US. The property of the Trust consists of an overriding royalty interest. The Royalty Interest entitles the Trust to receive the royalty from the production of crude oil and condensate from the working interest of BP Exploration (Alaska) Inc. in the Prudhoe Bay oil field located on the North Slope of Alaska.
About COSM Cosmos Health Inc.
Cosmos Health Inc is engaged in the nutraceuticals sector through its own proprietary lines of products 'Sky Premium Life' and 'Mediterranation'. Additionally, the firm is operating in the pharmaceutical sector through the provision of a broad line of branded over-the-counter drugs and branded and generic medicines. The company's focus will be on Branded Pharmaceuticals, Over-the-Counter medicines, and Generic Pharmaceuticals. It provides its products to wholesale drug distributors, wholesalers, and retail healthcare providers. The company's segment are Wholesale, Pharma Manufacturing, Nutraceuticals & Pharmaceuticals and Other. It derives maximum revenue from Wholesale Segment.